Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients
Date
2022
Authors
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Springer Nature
Abstract
Correction to: British Journal of Cancer 10.1038/s41416-021-01557-w, published online 06 October 2021
The original version of this article unfortunately contained a mistake in an author affiliation. Dr. Kouros Owzar was listed as “Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA”, when it should be “Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA”. The original article has been corrected.
Description
Keywords
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Quintanilha JCF, Wang J, Sibley AB, et al. Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. Br J Cancer. 2022;126(1):162. doi:10.1038/s41416-021-01617-1
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
British Journal of Cancer
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version